Latest News
30-Jul-2025 Piramal Health Cuts Loss to ₹82 cr in Q1
29-Jul-2025 Safeguards for Generic Drugs in UK FTA: Govt
29-Jul-2025 Maker of GLP1 Pens Scales Up for Generic Debuts
28-Jul-2025 Cheaper Cancer Care Therapy Earns Big Bucks for Pharma Co
25-Jul-2025 Zydus Moves Higher Bench in Cancer Drug Case
  more...
Latest Reports
Jul-25 Jun-25: IPM rebounds; Glenmark shining - Nuvama  
Jul-25 1QFY26 Preview: gRevlimid pricing pressures + late IPM surge - Emkay Research  
Jul-25 IPM: 11.5% value and 5% unit growth in Jun’25 - HDFC Securities  
Jul-25 Weighty opportunity: Indian CDMOs embracing GLP-1 fill-finish - ICICI Securities  
Jul-25 PHARMACEUTICALS AND HEALTHCARE - Nuvama  
  more...

Quarterly Summary March-2025
Desc Current Previous Per.Chg
Sales 29848.7 26038.6 14.6
Otherincome 1172.6 1168.1 0.4
Expense 22400.1 20728.5 8.1
RawMaterial 7428.0 6893.5 7.8
StaffCost 4279.7 3940.9 8.6
ExciseDuty 19.9 13.3 49.6
OtherExp 7136.3 6659.6 7.2
Interest 270.9 202.9 33.5
GrossProfit 9016.7 6956.6 29.6
Depreciation 1165.2 1182.3 -1.4
Tax 1674.7 1362.7 22.9
NetProfit 6581.1 4343.9 51.5
Total.Comp 45 -- --
Source: ETIG Database

Sectoral Companies As on 29 Jul 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 410460.25
Divi's Lab 177286.09
Torrent Phar 127536.04
Cipla 127139.85
Dr.Reddy's 108502.17
Mankind Phar 105356.12
Zydus Life 100091.75
Lupin 90635.19
Abbott (I) 73814.64
Aurobindo Ph 67853.08
Glenmark Pha 60869.13
Alkem Labora 60644.13
GlaxoSmith.P 53268.43
  click here for the complete list